Sampre Nutritions Limited has announced a revision to the record date for its upcoming stock split and bonus issue of equity shares. This corporate action, aimed at rewarding shareholders, has seen a slight delay in its timeline.

Key Details of the Revised Corporate Action

Implications for Shareholders

The company has confirmed that the bonus shares will be credited to the depository system by noon on November 12, 2025, ensuring that they are available for trading from November 13, 2025. This move allows shareholders an additional week to position themselves for the corporate action.

Regulatory Compliance

In its communication to the BSE, Sampre Nutritions emphasized its compliance with SEBI Circular SEBI/CIR/CFD/PoD/2024/122 dated September 16, 2024. The company has provided a Demat Request Number (DNR) range from 1 to 87,387,420 for the bonus issue.

Management Statement

Brahma Gurbani, Managing Director of Sampre Nutritions Limited, signed off on the regulatory filing, underlining the company's commitment to transparency and adherence to listing regulations.

This revision in the record date demonstrates Sampre Nutritions' attention to detail in executing corporate actions and ensures that shareholders have ample time to prepare for the upcoming changes in their holdings.

Sampre Nutritions Limited (SNL) has entered into a significant manufacturing agreement with Reliance Consumer Products Limited (RCPL), marking a notable development in the nutraceutical and food products sector. The deal, signed on October 8, 2025, is expected to boost Sampre Nutritions' revenue stream over the next three years.

Key Details of the Agreement

Terms and Conditions

Under the agreement, Sampre Nutritions will manufacture, pack, and supply confectionery, nutraceutical, and food products to RCPL. The production will adhere to RCPL's specifications and quality standards. Key points of the agreement include:

1. Pricing: Determined by RCPL based on the agreement's pricing mechanism
2. Payments: Made upon delivery of finished goods
3. Quality Control: Products to meet RCPL's prescribed specifications and standards
4. Ownership: Title and risk of goods remain with SNL until acceptance by RCPL at the designated delivery location

Impact and Implications

This agreement is expected to contribute significantly to Sampre Nutritions' revenues, potentially boosting its operations in the nutraceutical and food product segments. The deal aligns with the company's growth strategy and may enhance its market position in the confectionery and nutraceutical sectors.

Corporate Governance Aspects

It's worth noting that this agreement does not fall under related party transactions. As of the agreement date, there is no shareholding between the two companies, and neither party is related to the other's promoter groups. This transparency in corporate dealings underscores the arm's length nature of the transaction.

The manufacturing agreement between Sampre Nutritions and Reliance Consumer Products represents a strategic move in the competitive nutraceutical and food products industry. As the partnership unfolds over the next three years, it will be interesting to observe its impact on Sampre Nutritions' financial performance and market standing.